Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

IFT Meeting & Food Expo In Brief

This article was originally published in The Tan Sheet

  • News

Executive Summary

ADM unveils first Clarisoy application

You may also be interested in...



New Products In Brief

NBTY lines up nutritional Optimal Solutions for women’s health; Pharmavite touts Voots for tots; Langers boosts juices with DSM tomato extract; Solgar offers digestive support; more New Products In Brief.

New Products In Brief

NBTY lines up nutritional Optimal Solutions for women’s health; Pharmavite touts Voots for tots; Langers boosts juices with DSM tomato extract; Solgar offers digestive support; more New Products In Brief.

New Products In Brief

Blistex extends lip care offerings; Xlear Inc.’s Spry line tries cinnamon toothpaste; Natrol offers yoga-inspired supplements; diabetic first-aid from pharmaCline; more new OTC drugs and nutritionals.

Table

View full table

Related Content

HBW Insight
Pink Sheet
HBW Insight
Pink Sheet

Topics

Tags:
OTC Drugs
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS105129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By